Phase 1 dose de-escalation trial of the endogenous folate [6R]-5,10-methylene tetrahydrofolate in combination with fixed-dose pemetrexed as neoadjuvant therapy in patients with resectable rectal cancer

Background Modufolin® ([6R]-5,10-methylene tetrahydrofolate; [6R]-MTHF) is an endogenous biomodulator that is being developed as an alternative to leucovorin, a folate prodrug used in the treatment of colorectal cancer. The objective of this phase 1 dose de-escalation trial was to estimate the minim...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Invest New Drugs
Main Authors: Gustavsson, Bengt, Carlsson, Göran, Swartling, Torbjörn, Kurlberg, Göran, Derwinger, Kristoffer, Björkqvist, Hillevi, Odin, Elisabeth, Gibson, Fernando
Formáid: Artigo
Teanga:Inglês
Foilsithe: Springer US 2015
Ábhair:
Phase I Studies
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4768212/
https://ncbi.nlm.nih.gov/pubmed/26189513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-015-0272-0
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla